Publication | Closed Access
Is basiliximab induction, a novel risk factor for new onset diabetes after transplantation for living donor renal allograft recipients?
30
Citations
29
References
2014
Year
Basiliximab induction prevents acute rejection; however, it is associated with increased risk of NODAT.
| Year | Citations | |
|---|---|---|
Page 1
Page 1